Hangzhou Lead Biotech Co., Ltd.
PrivateLast Round
Series A
Extension
Jun 14, 2024
Company Overview
Hangzhou Lead Biotech Co., Ltd. is a pharmaceutical CDMO company that provides process R&D and manufacturing services for small molecule APIs and intermediates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Lead Biotech Co., Ltd. Comparables
Compare Hangzhou Lead Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioDuro-Sundia | 83% | |
| Asymchem | 80% | |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 80% |
For institutional investors. Book with your work email.
Hangzhou Lead Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 14, 2024 |
For institutional investors. Book with your work email.
Hangzhou Lead Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tasly Capital | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 14, 2024
Raised Series A Extension with Tasly Capital.
For institutional investors. Book with your work email.
Hangzhou Lead Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hangzhou Lead Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou Lead Biotech Co., Ltd. a public or private company?
Hangzhou Lead Biotech Co., Ltd. is a private company.
What is the current stock price of Hangzhou Lead Biotech Co., Ltd.?
Hangzhou Lead Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou Lead Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hangzhou Lead Biotech Co., Ltd. worth (valuation)?
Valuation information for Hangzhou Lead Biotech Co., Ltd. is not publicly available.
Can I buy Hangzhou Lead Biotech Co., Ltd. stock?
Hangzhou Lead Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hangzhou Lead Biotech Co., Ltd.'s last funding round?
Hangzhou Lead Biotech Co., Ltd.'s most recent funding round was Series A Extension on June 14, 2024.
Who are the main investors in Hangzhou Lead Biotech Co., Ltd.?
Key investors in Hangzhou Lead Biotech Co., Ltd. include Tasly Capital.
Will Hangzhou Lead Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Lead Biotech Co., Ltd..
How can I track Hangzhou Lead Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hangzhou Lead Biotech Co., Ltd.'s shares on secondary markets.